Jones; Bryan Edward
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jones; Bryan Edward.The latest application filed is for "anti-coronavirus antibodies and methods of use".
- Jones; Bryan Edward - San Diego CA
- Jones; Bryan Edward - Carmel IN
- Jones; Bryan Edward - Kimberley ZA
| Patent | Date |
|---|---|
| Anti-coronavirus antibodies and methods of use Grant 11,447,541 - Westendorf , et al. September 20, 2 | 2022-09-20 |
| Anti-coronavirus antibodies and methods of use Grant 11,370,828 - Westendorf , et al. June 28, 2 | 2022-06-28 |
| Anti-Coronavirus Antibodies and Methods of Use App 20210388066 - WESTENDORF; Kathryn ; et al. | 2021-12-16 |
| Anti-Coronavirus Antibodies and Methods of Use App 20210292393 - WESTENDORF; Kathryn ; et al. | 2021-09-23 |
| Method For Administering Glp-1 Molecules App 20150202296 - KHAN; Mohammed Amin ; et al. | 2015-07-23 |
| Method For Administering Glp-1 Molecules App 20140005106 - KHAN; Mohammed Amin ; et al. | 2014-01-02 |
| Formulation comprising GLP-1 Grant 8,492,330 - Khan , et al. July 23, 2 | 2013-07-23 |
| Treating acute renal failure with soluble thrombomodulin variants Grant 8,076,298 - Grinnell , et al. December 13, 2 | 2011-12-13 |
| Anti-myostatin antibodies Grant 8,066,995 - Davies , et al. November 29, 2 | 2011-11-29 |
| Method For Administering Glp-1 Molecules App 20110178006 - KHAN; Mohommed Amin ; et al. | 2011-07-21 |
| Method for administering GLP-1 molecules Grant 7,939,494 - Khan , et al. May 10, 2 | 2011-05-10 |
| TGF-beta binding antibodies Grant 7,927,593 - Jones , et al. April 19, 2 | 2011-04-19 |
| Tgf-beta Binding Antibodies App 20100136021 - Jones; Bryan Edward ; et al. | 2010-06-03 |
| Treating Acute Renal Failure With Soluble Thrombomodulin Variants App 20100087368 - Grinnell; Brian William ; et al. | 2010-04-08 |
| Anti-myostatin Antibodies App 20100080811 - DAVIES; JULIAN ; et al. | 2010-04-01 |
| Methods of treating diseases with activated protein C Grant 7,638,123 - Ciaccia , et al. December 29, 2 | 2009-12-29 |
| Anti-myostatin antibodies Grant 7,632,499 - Davies , et al. December 15, 2 | 2009-12-15 |
| Method For Administering Glp-1 Molecules App 20090286735 - Khan; Mohammed Amin ; et al. | 2009-11-19 |
| Passenger safety restraint, seat height adjustment assembly and method of restraining a passenger App 20090212549 - Jones; Bryan Edward | 2009-08-27 |
| Tgf-beta Binding Antibodies App 20090155285 - Jones; Bryan Edward ; et al. | 2009-06-18 |
| Anti-myostatin Antibodies App 20090131638 - Davies; Julian ; et al. | 2009-05-21 |
| TGF-.beta. binding antibodies Grant 7,494,651 - Jones , et al. February 24, 2 | 2009-02-24 |
| Tgf-Beta Binding Antibodies App 20080292638 - Jones; Bryan Edward ; et al. | 2008-11-27 |
| Methods Of Treating Diseases With Activated Protein C App 20070142293 - Ciaccia; Angelina Vucic ; et al. | 2007-06-21 |
| Methods of treating diseases with activated protein C Grant 7,204,981 - Ciaccia , et al. April 17, 2 | 2007-04-17 |
| Protein C derivatives App 20060204489 - Gerlitz; Bruce Edward ; et al. | 2006-09-14 |
| Protein C derivatives Grant 6,998,122 - Gerlitz , et al. February 14, 2 | 2006-02-14 |
| Protein C derivatives Grant 6,841,371 - Gerlitz , et al. January 11, 2 | 2005-01-11 |
| Protein c derivatives App 20030207435 - Gerlitz, Bruce Edward ; et al. | 2003-11-06 |
| Protein C derivatives Grant 6,630,138 - Gerlitz , et al. October 7, 2 | 2003-10-07 |
| Methods of treating diseases with activated protein c App 20030073632 - Ciaccia, Angelina Vucic ; et al. | 2003-04-17 |
| Protein c derivatives App 20030022354 - Gerlitz, Bruce Edward ; et al. | 2003-01-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 